Adverse Event Reporting for Pharmaceuticals

See this practice note for a discussion of adverse drug event reporting responsibilities in the pharmaceutical industry. The note provides guidance on creating a framework for compliance with U.S. Food and Drug Administration (FDA) requirements.

Read now »

Related Content

• FDA Food and Dietary Supplements Regulatory Activity Tracker
  Check this curated tracker regularly to monitor trends in the FDA’s regulation of food and dietary supplements.

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.

• New! Discover Practical Guidance Content and Resources
  Review this link for recent updates and this link for the newest additions to Practical Guidance. This guide is designed to help you find the tools and insights you need to work more efficiently and effectively.
  Review the Chevron Reversal Impact Resource Kit for analysis related to the Supreme Court’s decision to overturn four decades of deference to federal agency interpretations of ambiguous statutes.
  Document alerts allow you to stay current on legal developments that affect your practice. Find out how to set up your document alerts.
  The Practical Guidance Journal 2025 Edition One features guidance on what attorneys need to know about deepfake technology, a look ahead at AI risk management, an artificial intelligence checklist, and a review of cautions and key AI legal issues in DEI and employment discrimination.
  Browse the Practical Guidance Author Center to see the 2000+ leading attorney authors contributing to our 26 practice areas. Interested in becoming a Practical Guidance author? Click here for details. Practical Guidance is committed to amplifying diverse voices of attorneys across all differences, including gender and race.

PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+